(Q35045910)

6 August 2017

1 reference

title

Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production (English)

1 reference

systemic lupus erythematosus

6 August 2017

0 references

1 reference

1 reference

2

D A Isenberg

1 reference

6 August 2017

R A Mageed

1

1 reference

6 August 2017

1 January 2002

1 reference

6 August 2017

1 reference

6 August 2017

11

1 reference

6 August 2017

12

1 reference

6 August 2017

850-855

1 reference

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

6 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Novel concepts of tumor necrosis factor action in autoimmune pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Definition of microsatellite size variants for Tnfa and Hsp70 in autoimmune and nonautoimmune mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Analysis of restriction fragment length polymorphism in lymphokine genes of normal and autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

No independent association between a tumor necrosis factor-α promotor region polymorphism and insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU306RR

10.1191/0961203302LU306RR

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12529050